Azura Ophthalmics Limited Is A Clinical Stage Biopharmaceutical Company Based In Tel Aviv Yafoisraelthe Company Focuses On Developing Innovative Treatments For Ocular Surface Diseaseswith A Particular Emphasis On Meibomian Gland Dysfunctionmgd A Major Cause Of Dry Eye Disease The Company Is Pioneering A New Class Of Treatments Known As Ophthalmic Keratolyticswhich Aim To Address The Root Causes Of Various Ocular Conditionsone Of Its Key Productsazr Md 001Is Currently In A Phase 3 Clinical Trial To Evaluate Its Safety And Efficacy For Patients With Mgdazura Ophthalmics Also Utilizes A Novel Drug Delivery Platform To Enhance Treatment Effectivenessfurther Supporting Its Mission To Improve Patient Outcomes In Ocular Health Led By A Skilled Management Team With Extensive Experience In The Fieldazura Ophthalmics Is Dedicated To Addressing Significant Unmet Needs In Ocular Surface Diseases And Participates In Key Industry Events To Foster Innovation And Collaboration Within The Biopharmaceutical Community
No conferences found for this company.
| Company Name | Azura Ophthalmics Ltd |
| Country |
Israel
|
| Address | N/A |
| Telephone | N/A |
| N/A |
